← Eichor
Condition: Hyperkalemia Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Hyperkalemia

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Dietary Potassium Liberalization in Pre-Dialysis Patients
NA · 2 location(s) · University of Manitoba · NCT05090865
An Open-label Study to Assess Safety and Efficacy of SZC in Paediatric Patients With Hyperkalaemia
Phase 3 · 70 location(s) · AstraZeneca · NCT03813407
Patiromer for Treatment of Hyperkalaemia in Children Under 12 Years of Age
Phase 2 · 37 location(s) · Vifor Pharma, Inc. · NCT05766839
Potassium Correction for RAAS Optimization in Chronic Kidney Disease
Phase 4 · 1 location(s) · University Medical Center Groningen · NCT06256991
AK+ Guard™ Pilot Study in Chronic Kidney Disease: Outpatient Diagnostic Accuracy and Remote Monitoring
Phase N/A · 1 location(s) · AccurKardia, Inc. · NCT07210021
Monitoring Hyperkalemia Using Point-of-care AI-enabled ECG Device Among Patients With Chronic Kidney Disease Stages 3b-5
NA · 3 location(s) · Peking University First Hospital · NCT06901960
Chronic Kidney Disease, Hyperkalemia and Echocardiographic Changes
Phase N/A · 1 location(s) · Saglik Bilimleri Universitesi · NCT06635590
A Two-Part, Phase 3 Study Evaluating the Efficacy and Safety of WS016 for the Treatment of Hyperkalemia
Phase 3 · 50 location(s) · Waterstone Pharmaceutical (Wuhan) Co., LTD. · NCT07251309
Patiromer and Diet/hrQoL in Chronic Dialysis
Phase 3 · 1 location(s) · Mario Negri Institute for Pharmacological Research · NCT06858280
Prevalence and Risk Factors of Hyperkalemia in Non-Dialysis Chronic Kidney Disease Patients in Community
Phase N/A · 1 location(s) · Xiujuan Zang · NCT06940414
A Clinical Trial to Define the Best Strategy for the Management of Heart Failure in Elderly Patients
Phase 3 · 6 location(s) · Fundación para la Investigación del Hospital Clínico de Vale · NCT06578078
Observational Study on the Prevalence and Risk Factors of Patients With Hyperkalaemia in Brazil
Phase N/A · 1 location(s) · AstraZeneca · NCT07370194
Adding Urea to the Final Dialysis Fluid
Phase 1/Phase 2 · 1 location(s) · University of California, San Francisco · NCT06366230
Keeping RAASi Treatment With Optimal Potassium Control
Phase 3 · 5 location(s) · Fundación para la Investigación del Hospital Clínico de Vale · NCT06578533
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.